NCT06104917 - Effect of Maolactin on Gastrointestinal Tract (GIT) Health | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

July 23, 2025

Study Completion Date

July 23, 2025

Conditions

Gastrointestinal Dysfunction

Interventions

DRUG

High Dose Maolactin

Once daily dose of 2 capsules (2 capsules containing 250mg active proteins per capsule; equivalent to 500mg active proteins per day)

DRUG

Low Dose Maolactin

Once daily dose of 2 capsules (1 capsule containing 250mg active proteins per capsule and 1 capsule containing maltodextrin only; equivalent to 250mg active proteins per day)

DRUG

Maltodextrin

Once daily dose of 2 capsules

Trial Locations (1)

4006

RDC Clinical Pty Ltd, Brisbane